2024
DOI: 10.1186/s13000-024-01480-7
|View full text |Cite
|
Sign up to set email alerts
|

Development of crizotinib-associated renal cyst in a non-small cell lung cancer patient with ALK fusion: a case report and review of the literature

Peng Zhang,
JiaHua Xu,
Qing Wu
et al.

Abstract: Background Crizotinib, an oral first-generation tyrosine kinase inhibitor (TKI), is superior to systemic chemotherapy for the treatment of non-small cell lung cancer (NSCLC) with positive rearrangement of anaplastic lymphoma kinase (ALK). However, an increased incidence of renal and hepatic cysts has been reported in the patients on crizotinib treatment. Case presentation Here, we describe a case of a 71-year-old Chinese women developed multiple cy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 40 publications
0
0
0
Order By: Relevance